- Chris J Hendriksz, clinical lead and consultant transitional metabolic medicine1
- On behalf of D A Hughes, A B Mehta, J E Wraith, S E Jones, U Ramaswami, P Deegan, R Lachmann, E Murphy, T Hiwot, S V Vijay, F Stewart, M Cleary; Society for Mucupolysaccharide Diseases, Association for Glycogen Storage Disease (UK), Gauchers Association, Niemann-Pick Disease Group (UK)
- 1Salford Royal NHS Foundation Trust, Clinical Science Building B105, Salford M6 8HD, UK
- chris.hendriksz{at}srft.nhs.uk
It seems like déjà vu for those affected by rare diseases, and once again political change is to blame. Only two years ago the chief medical officer stated: “Services for those with rare diseases are fragmented and often poorly coordinated.”1
Commissioning of services for conditions individually affecting only 10% of the population presents challenges to value, fairness, and equity. Since 2005 the establishment of a UK National Commissioning Group for Rare Disorders (latterly National Specialist Commissioning Team) and Advisory Group for National Specialised Services …
Sign in
Article access
Article access for 1 day
Purchase this article for £20 $30 €32*
The PDF version can be downloaded as your personal record
PDF
Social bookmarking